J. Santos-Dias

Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk.

F. Reis, M. Bastos, F. Teixeira, 2005, The Journal of clinical endocrinology and metabolism.

Isosorbide-5-mononitrate treatment prevents cyclosporin A-induced platelet hyperactivation and the underlying nitric oxide-cyclic guanosine-3',5'-monophosphate disturbances.

F. Reis, F. Teixeira, M. Lourenço, 2003, Thrombosis research.

Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.

F. Reis, A. Santos-Silva, A. Dinis, 2007, Transplantation proceedings.